Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332 (3 June), doi:10.1136/bmj.332.7553.0-b
Use of selective COX 2 inhibitors is associated with a 1.4-fold increase in the risk of myocardial infarction, stroke, or vascular death compared with placebo; large doses of diclofenac and ibuprofen are also associated with an increased risk, whereas large doses of naproxen are not. In a meta-analysis of 138 randomised trials and almost 150 000 participants, Kearney and colleagues (p 1302) didn't have enough data to adequately assess whether the excess risk was dose dependent, but the hazard was not confined to long term use only.
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?